Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 82
Filter
Add more filters










Publication year range
1.
Nephron ; 136(2): 85-94, 2017.
Article in English | MEDLINE | ID: mdl-28178698

ABSTRACT

BACKGROUND: Chronic kidney disease (CKD) is common in patients with type 2 diabetes mellitus (T2DM) and limits therapeutic options. Dipeptidyl peptidase-4 (DPP-4) inhibitors represent a novel class of oral glucose-lowering agents and are known to be safe and effective in the general population. METHODS: We searched Cochrane, EMBASE, and PubMed from the time of their inception until March 2015. We included randomized controlled trials analyzing the efficacy (change in hemoglobin A1C [HbA1C]) and safety of DPP-4 agents in individuals with reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m2). We extracted study characteristics, participants' baseline characteristics, and safety outcomes from eligible studies. We performed a random effects meta-analysis to summarize the change in HbA1C and the relative risk of cardiovascular events in patients with T2DM and CKD. We also collected data on hypoglycemia, other serious adverse events, and mortality. RESULTS: We reviewed 12 studies with 4,403 patients with CKD and 239 on dialysis, finding a mean weighted decline in HbA1C of -0.48 (95% CI -0.61 to -0.35) with DPP-4 inhibitor therapy compared to placebo. DPP-4 inhibitors did not result in any additional adverse events, hypoglycemic episodes, or increased mortality. Restricting to studies with low risk of bias did not alter these findings. CONCLUSIONS: DPP-4 inhibitors can lower HbA1C without increasing the risk of cardiovascular or other major adverse events in patients with CKD. Few studies reported critical adverse events such as heart failure and hypersensitivity. If compared with other oral antiglycemic drugs, the effect of DPP-4 inhibitors is limited; however, their low risk of hypoglycemia may favor their use in patients with CKD. SUMMARY: This systematic review of DPP-4 inhibitors in CKD suggests that they reduce HbA1C by about 0.5%. Furthermore, there was not any increase in the risk for significant adverse events. More research is needed to determine the safety and efficacy of DPP-4 inhibitors in CKD.


Subject(s)
Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Renal Insufficiency, Chronic/drug therapy , Aged , Aged, 80 and over , Clinical Trials as Topic , Female , Glycated Hemoglobin/analysis , Humans , Male , Middle Aged , Randomized Controlled Trials as Topic
2.
Proc Inst Mech Eng H ; 226(8): 652-6, 2012 Aug.
Article in English | MEDLINE | ID: mdl-23057238

ABSTRACT

Quadruped joints are commonly used in musculoskeletal studies as a surrogate for human joints despite inherent differences in tissue properties. Although concerns exist regarding model validity, relatively few studies comparing the mechanical properties of quadruped tissue exist. This study aimed to characterise the regional intrinsic mechanical properties and thickness of tibiofemoral cartilage from three quadrupeds used in modern musculoskeletal research. Osteochondral plugs were removed from the major weight-bearing regions of porcine (6 months), bovine (18-24 months) and ovine (approximately 5 years) tibiofemoral joints. The equilibrium elastic modulus and permeability of the cartilage were derived by combining the creep indention deformation results and calculated tissue thickness within an in-silica model. Results showed significant interspecies and regional variation in cartilage thickness. Cartilage was thickest on porcine femoral condyles whereas ovine cartilage was consistently thinner across all sites. Furthermore, porcine tissue had a significantly lower equilibrium elastic modulus and significantly higher permeability than ovine cartilage. The results highlight the importance of considering the interspecies and regional variation in quadruped tissue properties when selecting animal joints for musculoskeletal investigations.


Subject(s)
Cartilage, Articular/physiology , Cartilage/anatomy & histology , Cartilage/physiology , Femur/physiology , Joints/physiology , Tibia/physiology , Animals , Cattle , Compressive Strength/physiology , Elastic Modulus/physiology , Hardness/physiology , In Vitro Techniques , Sheep , Species Specificity , Swine , Tensile Strength/physiology
3.
J Neurosurg Spine ; 10(4): 315-23, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19441988

ABSTRACT

OBJECT: The purpose of the study was to assess the effect of CSF and the size of the impacting bone fragment area on spinal cord deformation during trauma. METHODS: A transverse impact rig was used to produce repeated impacts on bovine and surrogate cord models. Tests were recorded with high-speed video and performed on specimens with and without CSF and/or dura mater and with 3 different impactor areas. RESULTS: The CSF layer was found to reduce the maximum cord deformation significantly. A 50% reduction in impact area significantly increased the maximum cord deformation by 20-30%. The surrogate model showed similar trends to the bovine model but with lower absolute deformation values. CONCLUSIONS: Cerebrospinal fluid protects the cord during impact by reducing its deformation. A smaller bone fragment impact area increases the deformation of the cord, in agreement with clinical results, where a higher impact energy-possibly giving rise to smaller fragments-results in a worse neurological deficit.


Subject(s)
Cerebrospinal Fluid , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Spinal Fractures/pathology , Spinal Fractures/physiopathology , Animals , Biomechanical Phenomena , Cattle , Dura Mater , In Vitro Techniques , Models, Animal , Spinal Cord Injuries/etiology , Spinal Fractures/complications , Videotape Recording
4.
Br J Dermatol ; 134(1): 134-7, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8745900

ABSTRACT

A case of graft-vs.-host disease (GVHD) arising solely within an area affected by piebaldism is described. The patient, a 35-year-old woman with a single hypopigmented patch on the right leg present since birth, had received an allogeneic bone marrow transplant (BMT) from an HLA-identical sibling donor, for treatment of a myelodysplastic syndrome (MDS). Beginning on day +38 post-BMT, the patch developed changes which were histologically consistent with GVHD. Syngeneic mixed epidermal cell-lymphocyte reaction (MECLR) testing of tissue from the patch, and from adjacent normal skin, showed differences which suggest that piebaldism-affected skin is immunologically different from normal skin. These findings may offer new insight into the pathophysiology of this disorder.


Subject(s)
Bone Marrow Transplantation/adverse effects , Graft vs Host Disease/etiology , Piebaldism/complications , Adult , Anemia, Refractory, with Excess of Blasts/therapy , Epidermis/immunology , Female , Graft vs Host Disease/pathology , Humans , Lymphocytes/immunology , Piebaldism/immunology , Piebaldism/pathology
5.
J Am Acad Dermatol ; 33(5 Pt 1): 734-40, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7593771

ABSTRACT

BACKGROUND: The eosinophilic ulcer is a rare lesion of the oral mucosa that has been infrequently described in the literature. OBJECTIVE: We attempted to characterize the history, demographics, clinical features, histologic features, pathogenesis, and treatment of the eosinophilic ulcer. METHODS: We observed three new cases of eosinophilic ulcer and reviewed the English-language literature. RESULTS: Eosinophilic ulcer occurs in any age group, without sex preference. The most common site in the oral cavity is the tongue, and the average size at diagnosis is 1.6 cm2. These lesions are often ulcerated, may be tender, and are sometimes multiple. The histologic features are characteristic but likely represent a spectrum of related disorders. Most eosinophilic ulcers will resolve spontaneously within a month. Recurrences are uncommon (< 15%). CONCLUSION: The eosinophilic ulcer is a benign, self-limited, reactive process of the oral mucosa of unknown origin. Its histologic features are characteristic but may be confused with atypical histiocytic granuloma and angiolymphoid hyperplasia with eosinophilia or, more importantly, lymphoma. This condition most likely represents a spectrum of related disorders with overlapping clinical and histologic features. After the diagnosis has been histologically confirmed, conservative management is suggested.


Subject(s)
Eosinophilia , Mouth Diseases , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Eosinophilia/complications , Eosinophilic Granuloma/pathology , Female , Humans , Infant , Male , Middle Aged , Mouth Diseases/pathology , Mouth Mucosa/pathology , Ulcer/pathology
6.
J Am Acad Dermatol ; 26(5 Pt 2): 805-13, 1992 May.
Article in English | MEDLINE | ID: mdl-1377207

ABSTRACT

A 56-year-old man had an 11-year history of a psoriasiform eruption of the palms, soles, and shins. An examination revealed well-demarcated patches and plaques of erythematous, fissured, and hyperkeratotic skin with focal erosions. There was no clinical evidence of ectodermal dysplasia. On histologic examination these lesions proved to be eccrine hamartomas that consisted of anastomosing cords and strands of cuboidal epithelial cells with well-formed ducts and a fibrovascular mucinous stroma. Eccrine ductal origin was indicated by histopathologic, histochemical, immunopathologic, and electron microscopic evaluation. These multiple palmoplantar eccrine hamartomas, unassociated with ectodermal dysplasia, represent a sporadic hamartomatous condition that is best designated as "eccrine syringofibroadenomatosis."


Subject(s)
Adenofibroma/diagnosis , Adenoma, Sweat Gland/diagnosis , Hand , Leg , Sweat Gland Neoplasms/diagnosis , Adenofibroma/pathology , Adenofibroma/ultrastructure , Adenoma, Sweat Gland/pathology , Adenoma, Sweat Gland/ultrastructure , Adolescent , Adult , Aged , Diagnosis, Differential , Female , Humans , Keratoderma, Palmoplantar/diagnosis , Male , Microscopy, Electron , Middle Aged , Skin/pathology , Skin/ultrastructure , Staining and Labeling/methods , Sweat Gland Neoplasms/pathology , Sweat Gland Neoplasms/ultrastructure , Sweat Glands/pathology , Sweat Glands/ultrastructure
7.
J Am Acad Dermatol ; 24(4): 598-602, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1827800

ABSTRACT

Both etretinate and its principal metabolite, acitretin, are efficacious in the treatment of psoriasis. Because patients with severe psoriasis often require chronic therapy, this study was undertaken to determine the efficacy, tolerability, and safety of acitretin in patients on continuous treatment for 12 months. The initial daily dose of 50 mg was taken for 4 weeks. Thereafter the dose was increased or decreased by 10 mg at monthly intervals (10 to 70 mg) to produce the optimal response with minimal toxicity. Seventy percent of the patients who completed 12 months of treatment showed marked improvement. All patients experienced adverse reactions; dry lips, hair loss, skin peeling, pruritus, and nail disorders were the most frequent. Fourteen patients were withdrawn from the study because of one or more intolerable adverse reactions.


Subject(s)
Psoriasis/drug therapy , Tretinoin/analogs & derivatives , Acitretin , Adult , Aged , Female , Humans , Male , Middle Aged , Psoriasis/pathology , Tretinoin/administration & dosage , Tretinoin/adverse effects , Tretinoin/therapeutic use
8.
Article in English | MEDLINE | ID: mdl-1947743

ABSTRACT

In the United States of American the medical device amendments of 1976 established a comprehensive system for regulation of medicaldevices intended for human use. One provision of the amendmentsestablishes three categories (classes) of devices depending on the regulatory controls needed to provide reasonable assurance of safety and effectiveness. The categories are as follows: Class I, General Controls; Class II, Performance Standards; and Class III, Premarket Approval. The performance characteristics of an immunology device that requires premarket approval (CLASS III) may be viewed as an extension of successfully completed scientific and laboratory investigations. Clinical trials of the device establish analyte levels in well-defined populations of healthy and diseased individuals and provide an estimate of the central tendency of analyte range. The performance characteristics of an immunoassay kit are established by laboratory studies, these studies include but are not limited to the following studies: reproducibility, recovery, linearity, stability, specificity, and sensitivity.


Subject(s)
Immunoassay/standards , Antibodies , Antigens, Neoplasm/analysis , Biomarkers, Tumor/analysis , Humans , Immunoassay/statistics & numerical data , Reproducibility of Results , Sensitivity and Specificity , United States , United States Food and Drug Administration
9.
Int J Dermatol ; 29(7): 477-8, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2228372
10.
J Rheumatol ; 16(6): 789-91, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2778761

ABSTRACT

A 2-center pilot study compared clinical and laboratory outcomes in 40 patients with psoriatic arthritis before and after treatment for 8 to 24 weeks with the vitamin A derivative, etretinate. The number of tender joints fell from 22.0 +/- 8.75 before treatment to 11.44 +/- 8.50 after treatment (p = .000). The duration of morning stiffness was 101.95 +/- 62.45 min before therapy and 44.53 +/- 82.10 min after treatment (p = 0.0004). Similar highly clinically and statistically significant improvement was seen in all clinical outcome measures and in the erythrocyte sedimentation rate. Primarily mucocutaneous side effects were seen in 39/40 patients and resulted in treatment termination before 24 weeks in 9 patients.


Subject(s)
Arthritis/drug therapy , Etretinate/therapeutic use , Psoriasis/drug therapy , Etretinate/adverse effects , Female , Humans , Male , Mucous Membrane/drug effects , Pain Measurement , Pilot Projects , Skin Diseases/chemically induced
11.
Gene ; 67(2): 301-5, 1988 Jul 30.
Article in English | MEDLINE | ID: mdl-2844631

ABSTRACT

A cloned DNA fragment, previously demonstrated to encode ribulose bisphosphate carboxylase/oxygenase (RuBisCO) of Chlorogloeopsis fritschii strain CCAP1411/1b, is shown also to include the entire transposable element, IS2, normally a resident in the Escherichia coli genome. Southern-blot hybridisation experiments confirm the presence of IS2 in the C. fritschii genome. This finding adds a new and unrelated species to the known host range of this element and provides evidence of genetic transfer between the Gram-negative E. coli and cyanobacteria. This may also have significance in relation to the nucleotide sequence rearrangements known to occur adjacent to RuBisCO and nif genes in other nitrogen-fixing cyanobacteria.


Subject(s)
DNA Transposable Elements , Base Sequence , Cyanobacteria/genetics , DNA/genetics , Genetic Vectors , Molecular Sequence Data , Nucleic Acid Hybridization
12.
Biochem Biophys Res Commun ; 139(3): 940-6, 1986 Sep 30.
Article in English | MEDLINE | ID: mdl-3094529

ABSTRACT

The uptake and metabolism of proline by Anabaena 7120 is demonstrated. Uptake is linear over the first hour and it appears that the rate of proline oxidation is sufficient to account for growth is suggested by the finding that exogenous proline represses heterocyst differentiation and inhibits nitrogen fixation in Anabaena 7120, without affecting growth rate.


Subject(s)
Cyanobacteria/metabolism , Nitrogen Fixation , Proline/metabolism , Oxidation-Reduction , Proline Oxidase/metabolism , Time Factors
13.
Gene ; 35(3): 297-303, 1985.
Article in English | MEDLINE | ID: mdl-3899862

ABSTRACT

The ntrA gene from Klebsiella pneumoniae has been cloned and the product identified as a 76-kDal acidic polypeptide. An ntrA::lacZ fusion was used to demonstrate that expression of ntrA is not controlled by the nitrogen regulation (ntr) system and is independent of the nitrogen status of the cell. Studies with multicopy plasmids carrying ntrA and rpoD suggest that the ntrA product competes with the rpoD product (sigma 70 of RNA polymerase) in mediating transcription initiation by RNA polymerase at ntrA-dependent promoters. No significant homology between ntrA and rpoD was detected by Southern blotting.


Subject(s)
Klebsiella pneumoniae/genetics , Transcription Factors/genetics , Bacterial Proteins/genetics , Cloning, Molecular , Gene Expression Regulation , Genes, Bacterial , Nitrogen Fixation
14.
Planta ; 163(3): 424-9, 1985 Mar.
Article in English | MEDLINE | ID: mdl-24249416

ABSTRACT

The filamentous cyanobacterium Spirulina platensis has been examined for salt tolerance and osmotic adjustment. Salinities up to 150% seawater had little effect on growth yield or photosynthetic O2 evolution; higher salinities were markedly inhibitory. Osmotic adjustment was achieved by the intracellular accumulation of the low-molecular-weight carbohydrate glucosyl-glycerol in response to increased external salinity: in fullstrength (100%) seawater glucosyl-glycerol accounted for approximately 5.0% of the dry weight of the cyanobacterium. Trehalose was also present, particularly in cells at low salt concentration, and in 50% seawater medium accounted for up to 1.0% of the dry weight of the cyanobacterium. For cells grown in 100% seawater the ratio of trehalose to glucosyl-glycerol varied with temperature: at 37°C trehalose comprised 31% (w/w) of the low-molecular-weight carbohydrates while at 20°C only 9% of the total was trehalose. When subjected to hypo-osmotic shock the intracellular concentration of glucosyl-glycerol decreased and this was mirrored by an increase in glycogen. An understanding of the osmotic adjustment of S. platensis has implications both for the mass culturing of this and other strains of Spirulina and possibly also for the quality of the harvested product.

15.
J Am Acad Dermatol ; 11(2 Pt 2): 364-7, 1984 Aug.
Article in English | MEDLINE | ID: mdl-6480943

ABSTRACT

Xeroderma pigmentosum (XP) is associated with an increased frequency of cutaneous malignancies including malignant melanoma. We report a patient who developed eleven primary melanomas and numerous highly atypical nevi in addition to the basal cell carcinomas and squamous cell carcinomas more commonly seen in patients with XP.


Subject(s)
Melanoma/pathology , Neoplasms, Multiple Primary/pathology , Skin Neoplasms/pathology , Xeroderma Pigmentosum/pathology , Adult , Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Female , Humans , Hyperplasia , Melanoma/secondary , Skin/pathology , Skin Neoplasms/secondary
16.
Eur J Biochem ; 141(3): 497-504, 1984 Jun 15.
Article in English | MEDLINE | ID: mdl-6146520

ABSTRACT

Thioredoxin has been purified to homogeneity from the cyanobacterium Anabaena cylindrica. The protein consists of a single polypeptide chain with a relative molecular mass of about 11 680 which has two cysteine residues (residues 31 and 34) in the sequence-Cys-Gly-Pro-Cys- and an isoelectric point at pH 4.55. The N-terminal amino acid sequence of 39 residues shows distinct homologies with the sequences of Escherichia coli and Corynebacterium nephridii thioredoxins. Anti-(A. cylindrica thioredoxin) antiserum was used to quantify the thioredoxin which constituted about 0.22% of the soluble protein in cell-free extracts of N2-fixing, NO3- -grown or NH4+-grown A. cylindrica. Activation of fructose-1,6-bisphosphatase of A. cylindrica, activation of glutamine synthetase and NADP+-dependent malate dehydrogenase of the green alga Scenedesmus obliquus but not of A. cylindrica, and deactivation of glucose-6-P dehydrogenase of the cyanobacterium Anabaena variabilis were all achieved using the same thioredoxin species. No other thioredoxin species were detected in extracts of A. cylindrica when examined for the activation of these enzymes.


Subject(s)
Bacterial Proteins/isolation & purification , Cyanobacteria/analysis , Thioredoxins/isolation & purification , Amino Acid Sequence , Amino Acids/analysis , Chemical Phenomena , Chemistry , Cyanobacteria/metabolism , Electrophoresis/methods , Fructose-Bisphosphatase/metabolism , Glucosephosphate Dehydrogenase/metabolism , Glutamate-Ammonia Ligase/metabolism , Immunoelectrophoresis/methods , Malate Dehydrogenase/metabolism , Nitrogen Fixation , Thioredoxins/metabolism
17.
J Appl Bacteriol ; 56(1): 109-15, 1984 Feb.
Article in English | MEDLINE | ID: mdl-6423604

ABSTRACT

The effect of the lytic phage LPP-DUN1 on the cyanobacterium Plectonema boryanum has been investigated in batch and in continuous cultures in the presence and absence of silt. In batch culture Plectonema without added phage grew normally; the presence of phage caused rapid lysis of the cyanobacterium and the addition of silt prevented lysis by the phage. In continuous culture the numbers of cyanobacterial cells and phage particles oscillated in a reciprocal manner, but the addition of silt damped down the oscillations in Plectonema biomass without decreasing the numbers of phage particles isolated from the cultures. The presence of silt thus appears to protect the cyanobacterium from lysis by phage, although the total numbers of phage particles are relatively unaffected by the silt, at least in the short-term.


Subject(s)
Bacteriophages/physiology , Cyanobacteria/growth & development , Culture Media , Suspensions
18.
J Am Acad Dermatol ; 9(2): 252-6, 1983 Aug.
Article in English | MEDLINE | ID: mdl-6350384

ABSTRACT

A patient with long-standing dermatitis herpetiformis (DH) developed histiocytic lymphoma of the small bowel. This is the twelfth reported case of lymphoma occurring in association with dermatitis herpetiformis.


Subject(s)
Dermatitis Herpetiformis/complications , Jejunal Neoplasms/complications , Lymphoma, Large B-Cell, Diffuse/complications , Dermatitis Herpetiformis/pathology , Female , Fluorescent Antibody Technique , Humans , Jejunal Neoplasms/ultrastructure , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Middle Aged , Skin/ultrastructure
19.
Ann Microbiol (Paris) ; 134B(1): 205-28, 1983.
Article in English | MEDLINE | ID: mdl-6139055

ABSTRACT

N2-fixing heterocystous cyanobacteria develop in symbiotic association with a small number of eukaryotic plant species belonging to the algae, fungi, liverworts, ferns, gymnosperms and angiosperm. When the free-living cyanobacteria develop in symbiosis, they become modified morphologically, physiologically and biochemically. The symbiosis are relatively specific, and among the changes which occur in the endophytic cyanobacteria are increases in the size of the vegetative cells, changes in the ultrastructure of the vegetative cells, a tendency for a reduction in the filamentous habit, an increased heterocyst frequency when another photosynthetic partner is present, reduced activities of glutamine synthetase and glutamate synthase, and NH4+ release by; the endophytic cyanobacteria. These and other aspects are considered, emphasizing, in particular, work carried out in the authors' laboratory.


Subject(s)
Cyanobacteria/physiology , Eukaryota/physiology , Fungi/physiology , Plants/microbiology , Symbiosis , Cyanobacteria/ultrastructure , Glutamate Synthase/metabolism , Glutamate-Ammonia Ligase/metabolism , Lichens/physiology , Movement , Nitrogen Fixation , Plants/metabolism , Quaternary Ammonium Compounds/metabolism
20.
Biochem Biophys Res Commun ; 114(1): 206-13, 1983 Jul 18.
Article in English | MEDLINE | ID: mdl-6136275

ABSTRACT

Purified glutamine synthetase from the cyanobacterium Anabaena cylindrica required a divalent cation for activity. Maximum biosynthetic activity required Mg2+ (25 mM when supplied alone). Co2+ and Mn2+ each supported up to 20% of this activity; 12 other cations tested were ineffective. At 2.5 - 10 mM Mg2+, 0.1 mM Co2+ or ethylene glycol-bis-(beta-aminoethyl ether) N,N'-tetraacetic acid (EGTA) stimulated GS activity to maximum rates; other divalent cations (particularly Mn2+) inhibited Mg2+-dependent activity. At 5 mM Mg2+ the Kappm for NH+4 (0.05 mM) was 20-fold lower than at 25 mM Mg2+; added Co2+ did not markedly alter this low Km for NH+4; this could be physiologically important.


Subject(s)
Cyanobacteria/enzymology , Glutamate-Ammonia Ligase/metabolism , Ammonia/pharmacology , Cations, Divalent , Cobalt/pharmacology , Glutamate-Ammonia Ligase/isolation & purification , Kinetics , Magnesium/pharmacology , Manganese/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...